Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole effect on HSK31858 pharmacokinetics in healthy subjects
NCT07134465Phase 1Enrolling by invitation
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Aug 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of HSK31858, sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoints: Maximum Plasma Concentration at 216 hours and Area Under the Curve from Time Zero to Infinity at 216 hours. Started Aug 2025; status: enrolling by invitation.
02
Drugs
HSK31858
Beyond the preview
Go deeper on NCT07134465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07134465.